VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19

BACKGROUND: Nirmatrelvir–ritonavir has been authorized for emergency use by many countries for the treatment of coronavirus disease 2019 (Covid-19). However, the supply falls short of the global demand, which creates a need for more options. VV116 is an oral antiviral agent with potent activity agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Zhujun, Gao, Weiyi, Bao, Hong, Feng, Haiyan, Mei, Shuya, Chen, Peizhan, Gao, Yueqiu, Cui, Zhilei, Zhang, Qin, Meng, Xianmin, Gui, Honglian, Wang, Weijing, Jiang, Yimei, Song, Zijia, Shi, Yiqing, Sun, Jing, Zhang, Yifei, Xie, Qing, Xu, Yiping, Ning, Guang, Gao, Yuan, Zhao, Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812289/
https://www.ncbi.nlm.nih.gov/pubmed/36577095
http://dx.doi.org/10.1056/NEJMoa2208822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812289/
https://www.ncbi.nlm.nih.gov/pubmed/36577095
http://dx.doi.org/10.1056/NEJMoa2208822

Ejemplares similares